Ductal carcinoma in situ of the breast in men: A review

Itzhak Pappo*, Ilan Wasserman, Ariel Halevy

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Breast carcinoma in men is rare and comprises approximately 1% of all breast cancer cases. In contrast to the increase in the detection rate of ductal carcinoma in situ (DCIS) in women resulting from the wide use of screening mammography programs, the rate of male DCIS is still small and represents approximately 5% of all male breast cancers. Considerable debate exists concerning the nature of this entity, including the clinical course, pathologic findings, treatment, and prognosis. In this review, the relevant literature dealing with male DCIS is summarized in an attempt to more precisely define the features of this disease.

Original languageEnglish
Pages (from-to)310-314
Number of pages5
JournalClinical Breast Cancer
Issue number4
StatePublished - Oct 2005
Externally publishedYes


  • BRCA2 mutation
  • Intraductal carcinoma
  • Malignant neoplasm
  • Papillary carcinoma


Dive into the research topics of 'Ductal carcinoma in situ of the breast in men: A review'. Together they form a unique fingerprint.

Cite this